Login to Your Account

Other News To Note

Tuesday, March 27, 2012
• GenVec Inc., of Gaithersburg, Md., said it received a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to support the firm's malaria vaccine program. The grant, valued at about $600,000 over two years, will be used to identify highly protective antigens for malaria vaccine development and will build on research started under a Small Business Innovation Research grant awarded from the NIAID in 2009.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription